Given that PPARγ has been reported as a potential tumor suppressor in various types of cancers, it is of interest to ask if the metabolic function of PPARγ, in particular lipid metabolism, would have something to do with its tumor suppressive function in lung cancer, which was previously shown to be PPARγ-sumoylation dependent [15]. This evidence concerns the gene PPARG and cancer.